These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2097153)

  • 21. The trend of serum CA125 levels during the first three courses of chemotherapy as a predictor of second-look findings in patients with ovarian carcinoma.
    Gadducci A; Ferdeghini M; Bartolini T; Facchini V; Mariani G; Bianchi R; Fioretti P
    J Nucl Med Allied Sci; 1989; 33(3):243-6. PubMed ID: 2778499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma lipid-associated sialic acid and serum CA 125 as indicators of disease status with advanced ovarian cancer.
    Vardi JR; Tadros GH; Foemmel R; Shebes M
    Obstet Gynecol; 1989 Sep; 74(3 Pt 1):379-83. PubMed ID: 2761915
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive value of CA 125 during early chemotherapy of advanced ovarian cancer.
    Mogensen O; Mogensen B; Jakobsen A
    Gynecol Oncol; 1990 Apr; 37(1):44-6. PubMed ID: 2323611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radioimmunoassay of the CA 12 5 antigen in ovarian carcinomas: advantages compared with CA 19-9 and CEA.
    Ricolleau G; Chatal JF; Fumoleau P; Kremer M; Douillard JY; Curtet C
    Tumour Biol; 1984; 5(3-4):151-9. PubMed ID: 6594738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum CA 125 levels in epithelial ovarian cancer: relation with findings at second-look operations and their role in the detection of tumour recurrence.
    Schilthuis MS; Aalders JG; Bouma J; Kooi H; Fleuren GJ; Willemse PH; De Bruijn HW
    Br J Obstet Gynaecol; 1987 Mar; 94(3):202-7. PubMed ID: 3471274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preoperative serum CA-125 levels in early stage ovarian cancer.
    Patsner B
    Eur J Gynaecol Oncol; 1990; 11(5):319-21. PubMed ID: 2097148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical relevance of the CA 125 assay in monitoring of ovarian cancer patients.
    Hising C; Anjegård IM; Einhorn N
    Am J Clin Oncol; 1991 Apr; 14(2):111-4. PubMed ID: 2028919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum half-life of the tumor marker CA 125 during induction chemotherapy as a prognostic indicator for survival in ovarian carcinoma.
    Högberg T; Kågedal B
    Acta Obstet Gynecol Scand; 1990; 69(5):423-9. PubMed ID: 2270768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is CA-125 monitoring useful in patients with epithelial ovarian carcinoma and preoperative negative CA-125 serum levels?
    Sevelda P; Rosen A; Denison U; Barrada M; Spona J; Salzer H
    Gynecol Oncol; 1991 Nov; 43(2):154-8. PubMed ID: 1743558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The relationship between 111In-labelled immunoscintigraphy and serum CA-125 levels in ovarian carcinoma patients postchemotherapy.
    Prosser ES; Pomeroy M; Barker F; Carroll K; Davis M; Duffy J; Duffy G; Fennelly JJ; O'Kennedy R
    Biochem Soc Trans; 1992 Feb; 20(1):54S. PubMed ID: 1633979
    [No Abstract]   [Full Text] [Related]  

  • 31. CA-125 in gynecological malignancies.
    Meier W; Stieber P; Fateh-Moghadam A; Eiermann W; Hepp H
    Eur J Cancer Clin Oncol; 1987 Jun; 23(6):713-7. PubMed ID: 2443359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The biological tumor markers' myopia: a model with CA 125 and second-look in ovarian cancer.
    Zanaboni F; Accinelli G; Colombo P; Jelmoni G; Morandi C; Pedronetto S; Sbernini R; Bolis G
    Int J Biol Markers; 1987; 2(2):105-8. PubMed ID: 3482860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coordinate elevation of serum markers in ovarian cancer but not in benign disease.
    Bast RC; Knauf S; Epenetos A; Dhokia B; Daly L; Tanner M; Soper J; Creasman W; Gall S; Knapp RC
    Cancer; 1991 Oct; 68(8):1758-63. PubMed ID: 1913520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The serum concentrations of TAG-72 antigen measured with CA 72-4 IRMA in patients with ovarian carcinoma. Preliminary data.
    Gadducci A; Ferdeghini M; Ceccarini T; Prontera C; Facchini V; Bianchi R; Fioretti P
    J Nucl Med Allied Sci; 1989; 33(1):32-6. PubMed ID: 2746365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma D-dimer and peritoneal CA-125 levels as predictors of disease status in ovarian carcinoma.
    Rose PG; Terrien JM; Baker S
    J Surg Oncol; 1994 Jul; 56(3):168-71. PubMed ID: 8028348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison between serum CA 125 and CA 19-9 assays and tissular OC 125 and 1116NS 19-9 reactivity in malignant and benign ovarian tumors.
    Gadducci A; Ciancia EM; Malagnino G; De Luca F; Campani D; Ferdeghini M; Facchini V; Pingitore R; Fioretti P
    Eur J Gynaecol Oncol; 1992; 13(4):346-54. PubMed ID: 1516586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The prognostic significance of the half-life of serum CA 125 in patients responding to chemotherapy for epithelial ovarian carcinoma.
    Hawkins RE; Roberts K; Wiltshaw E; Mundy J; Fryatt IJ; McCready VR
    Br J Obstet Gynaecol; 1989 Dec; 96(12):1395-9. PubMed ID: 2620051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical use of CA-125 in gynecology. Preliminary experience].
    Mayerson D; Badía J; Wild R; Barrena N; Johnson MC; Foradori A
    Rev Chil Obstet Ginecol; 1989; 54(5):301-6. PubMed ID: 2490419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Ovarian carcinoma antigen (CA 125) and ovarian cancer (clinical follow-up and prognostic studies)].
    Göcze P; Vahrson H
    Orv Hetil; 1993 Apr; 134(17):915-8. PubMed ID: 8479736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of two new assays for tumor-associated antigens, CASA and OSA, found in the serum of patients with epithelial ovarian carcinoma--comparison with CA125.
    McGuckin MA; Layton GT; Bailey MJ; Hurst T; Khoo SK; Ward BG
    Gynecol Oncol; 1990 May; 37(2):165-71. PubMed ID: 1693126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.